Morris Robert E, Parma Edward Scott, Robin Nathaniel H, Sapp Mathew R, Oltmanns Matthew H, West Matthew R, Fletcher Donald C, Schuchard Ronald A, Kuhn Ferenc
Retina Specialists of Alabama, Birmingham, AL, USA.
Helen Keller Foundation for Research and Education, Birmingham, AL, USA.
Clin Ophthalmol. 2021 Jan 6;15:19-29. doi: 10.2147/OPTH.S284441. eCollection 2021.
To introduce a novel technique of encircling laser prophylaxis (ora secunda cerclage Stickler syndrome, OSC/SS) to prevent rhegmatogenous retinal detachment (RRD) in Stickler syndrome eyes.
After first eye RRD at age 50 and at age 18, respectively, a 53-year-old father and his 22-year-old son with type 2 SS (STL2) gave informed consent and underwent OSC/SS prophylaxis, performed in each fellow eye. A 26-year-old STL2 daughter then suffered first eye retinal detachment and similarly chose fellow eye OSC/SS prophylaxis. A second son, 28 years of age with STL2, chose OSC/SS prophylaxis in both eyes.
The three OSC/SS treated fellow eyes have gone 12 years, 11 years, and 8 years without RRD. STL1 and less common STL2 eyes are known to have a similar rate of RRD, and 80% of STL1 fellow eyes develop RRD at a median of 4 years in the absence of prophylaxis. Moreover, five of six (83%) known STL2 family members suffered RRD, only the STL2 son with bilateral OSC/SS remaining bilaterally attached. All five OSC/SS treated eyes (average 8.7 years post-prophylaxis) retained preoperative visual acuity of 20/20 to 20/30, with an average, asymptomatic reduction of meridional field in each eye to 50 degrees. In contrast, in the three eyes having suffered RRD prior to presentation, visual acuity ranged from 20/125 to 8/200 and average meridional field was 29 degrees.
Encircling grid laser (OSC) modified in Stickler eyes to encompass the ora serrata and extend posteriorly to and between the vortex vein ampullae (OSC/SS) is a reasonable RRD prophylaxis option to offer STL1 and STL2 patients as an alternative to no treatment or less effective prophylaxis. Because of rarity and severity, the ultimate proof of safety and efficacy will likely come not from randomized trials, but from a non-randomized, prospective, cohort comparison study of such individual efforts.
介绍一种新型的环形激光预防性治疗技术(锯齿缘后环形光凝治疗 Stickler 综合征,OSC/SS),以预防 Stickler 综合征患者发生孔源性视网膜脱离(RRD)。
分别在 50 岁和 18 岁时,一只眼睛发生 RRD 后,一名 53 岁的父亲和他 22 岁的患有 2 型 Stickler 综合征(STL2)的儿子签署知情同意书,并在各自的对侧眼接受了 OSC/SS 预防性治疗。一名 26 岁的 STL2 型女儿随后患了第一只眼睛的视网膜脱离,同样选择了对侧眼的 OSC/SS 预防性治疗。另一个 28 岁的患有 STL2 的儿子选择了双眼的 OSC/SS 预防性治疗。
接受 OSC/SS 治疗的三只对侧眼分别在 12 年、11 年和 8 年未发生 RRD。已知 STL1 型和较罕见的 STL2 型眼睛发生 RRD 的概率相似,并且在没有预防性治疗的情况下,80%的 STL1 型对侧眼在中位时间 4 年时会发生 RRD。此外,已知的 STL2 型家族成员中有六分之五(83%)发生了 RRD,只有接受双侧 OSC/SS 治疗的 STL2 型儿子双眼未发生脱离。所有接受 OSC/SS 治疗的眼睛(预防性治疗后平均 8.7 年)保持术前 20/20 至 20/30 的视力,每只眼睛的子午线视野平均无症状性缩小至 50 度。相比之下,在就诊前发生 RRD 的三只眼睛中,视力范围为 20/125 至 8/200,平均子午线视野为 29 度。
在 Stickler 综合征患者眼中改良的环形格栅激光(OSC),使其环绕锯齿缘并向后延伸至涡静脉壶腹及其之间(OSC/SS),是一种合理的 RRD 预防性治疗选择,可为 STL1 型和 STL2 型患者提供替代不治疗或效果较差的预防性治疗的方案。由于该病罕见且严重,安全性和有效性的最终证据可能并非来自随机试验,而是来自对这些个体治疗进行的非随机、前瞻性队列比较研究。